Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Gains from Investment Securities: 2023-2024

Historic Gains from Investment Securities for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $364,000.

  • Camp4 Therapeutics' Gains from Investment Securities fell 318.89% to -$197,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $189,000, marking a year-over-year change of. This contributed to the annual value of $364,000 for FY2024, which is 73.94% down from last year.
  • Per Camp4 Therapeutics' latest filing, its Gains from Investment Securities stood at $364,000 for FY2024, which was down 73.94% from $1.4 million recorded in FY2023.
  • Over the past 5 years, Camp4 Therapeutics' Gains from Investment Securities peaked at $1.4 million during FY2023, and registered a low of $364,000 during FY2024.
  • For the 2-year period, Camp4 Therapeutics' Gains from Investment Securities averaged around $880,500, with its median value being $880,500 (2023).
  • Data for Camp4 Therapeutics' Gains from Investment Securities shows a maximum YoY plummeted of 73.94% (in 2024) over the last 5 years.
  • Over the past 2 years, Camp4 Therapeutics' Gains from Investment Securities (Yearly) stood at $1.4 million in 2023, then slumped by 73.94% to $364,000 in 2024.